Abiopharma

Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

PepsiCo Announces Timing and Availability of Second-Quarter 2026 Financial Results

Visa and Brale Explore Private Stablecoin Settlement for Institutional Payments

LanzaTech JV Successful IPO Underscores Strategic Value of More Secure Fuel Supply

GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities

LCI Industries Announces Leadership Transitions

Rights Offering and Identifying Details for New Securities-MYDAS R6

Zoetis - Zoetis Shares Resources and Tips for New World Screwworm Response and Management

Nu Holdings Announces US$1.0 Billion Share Repurchase Program